The prothrombin time (PT) is the number of seconds plasma takes to clot through the extrinsic and common pathways: factors VII, X, V, prothrombin and fibrinogen. Because reagents differ, the PT is reported as the international normalized ratio (INR) so results compare across labs. The INR is the test used to adjust warfarin. It is also ordered for unexplained bleeding, before procedures, and to judge liver synthetic function.
Checked against the sources below November 2026
Normal range
Test
US units
SI units
Notes
PT
11–13.5 seconds
11–13.5 seconds
INR
0.8–1.1
0.8–1.1
Therapeutic on warfarin usually 2–3
Adult ranges. Ranges differ a little between laboratories; use the range printed on your lab’s report. All coagulation values
PT and INR in the ICU
Argatroban for HIT raises the INR on its own, so the INR during overlap with warfarin overstates the warfarin effect. Per the label, check the INR daily; at usual doses argatroban can be stopped when the combined INR is above 4, with a recheck in 4 to 6 hours.
Factor VII has the shortest life of the vitamin K factors, so the PT is the first test to drift up in early vitamin K deficiency, early warfarin effect and early liver failure.
A prolonged PT and aPTT together with a low platelet count suggests DIC rather than warfarin or vitamin K deficiency, so read the INR next to the platelet count.
Direct oral anticoagulants that block thrombin or factor Xa can prolong the PT, so note the drug and the time of the last dose when reading a high INR.
Per the warfarin label, prothrombin complex concentrate, plasma or activated factor VII may be considered when reversal is urgent; vitamin K reverses more slowly and blunts the response to later warfarin doses.
Prolonged PT and high INR
Off anticoagulants, a result above the range is flagged, and above 1.5 usually means a real clotting problem. On warfarin, most targets are 2 to 3; above 4 adds bleeding risk without added benefit.
Causes
Warfarin, the most tested cause
Vitamin K deficiency
Liver disease, since the liver makes most clotting factors
Disseminated intravascular coagulation (DIC)
Direct oral anticoagulants, and argatroban, which raises the INR on its own
Inherited factor VII deficiency
Signs and symptoms
Bruising and bleeding from cuts that will not stop
Bleeding gums or nosebleeds
Red, pink or brown urine
Red or black, tarry stools
Vomiting blood or coffee-ground emesis
Headache or neuro change that can signal brain bleeding
Nursing actions
Compare the INR with the client's target range before giving warfarin
Hold warfarin and report an INR above the target range, especially above 4, per facility policy
Assess for bleeding: skin, gums, urine, stool, emesis and neuro status
Anticipate an order for vitamin K when the INR is high, and for prothrombin complex concentrate or plasma with serious bleeding
Use bleeding precautions and apply pressure to puncture sites
Review new medicines and supplements, since they can change the INR
Teach the client to report black stools, blood in urine and unusual bruising
Subtherapeutic INR on warfarin
An INR below the client's target range means warfarin is not yet protecting against clots. For most indications that means an INR below 2, or below 2.5 for a mechanical mitral valve.
Causes
A sudden increase in vitamin K foods, such as leafy greens
Vitamin K given recently to reverse warfarin
Warfarin recently started, before the INR has reached range
Interacting drugs or supplements, including vitamin K supplements
Signs and symptoms
Often no symptoms until a clot forms
Leg pain, swelling or warmth from a deep vein clot
Sudden dyspnea, pleuritic chest pain or tachycardia from a pulmonary embolism
Nursing actions
Report an INR below the target range to the prescriber
Ask about diet changes, recent vitamin K and new medicines or supplements
Assess for signs of a clot in the legs, lungs and brain
Anticipate an order to change the warfarin dose
Teach a steady, not zero, intake of vitamin K foods such as leafy greens
Teach the client to keep every INR appointment, since the dose is set by the result
Drawing and reading the sample
Clients on warfarin may be told to delay the daily dose until after the blood draw
The INR is checked daily when warfarin is started, then every 1 to 4 weeks once stable
Vitamin K in food, soybean and canola oil, high-fat meals and alcohol can change the result
The PT does not prolong until a tested factor is about 70% deficient, so a normal PT does not rule out every factor problem
On the exam
Warfarin is followed with the INR; heparin is followed with the aPTT
The antidote for warfarin is vitamin K; teach a consistent intake of leafy greens, not avoidance
An INR of 2 to 3 is the usual warfarin goal; an INR well above the goal with bleeding is the priority client
A rising INR in a client with liver failure reflects poor factor production, not anticoagulation
Check yourself: 3 questions
Question 1 · Advanced ICU Pharmacology
A patient received a bileaflet mechanical mitral valve and is starting warfarin. Which INR target is MOST appropriate?
4.5 (range 4.0–5.0)
2.5 (range 2.0–3.0)
3.0 (range 2.5–3.5)
2.0 (range 1.5–2.5)
Show the answer and rationale
Answer: C
A. This target greatly increases bleeding risk without added benefit.
B. This is the usual target for a bileaflet mechanical aortic valve without risk factors.
C.Correct. Mechanical mitral valves have a higher thrombosis risk and require a higher target than mechanical aortic valves.
D. This range is too low for a mechanical mitral valve.
For mechanical valves, the INR target depends on valve position and thrombosis risk. A mechanical mitral valve, or a mechanical aortic valve with risk factors (AF, prior thromboembolism, LV dysfunction, hypercoagulable state, or an older valve design), has a target of 3.0 (2.5–3.5). A bileaflet mechanical aortic valve without risk factors targets 2.5 (2.0–3.0), and some newer valves are approved for lower targets after 3 months. Heparin bridging continues until the INR is therapeutic.
A patient taking warfarin for a mechanical aortic valve presents with a new intracerebral hemorrhage. The INR is 3.2. Which reversal plan is MOST appropriate?
Protamine sulfate 50 mg by slow IV injection
Two units of fresh frozen plasma given alone
4-factor PCC plus IV vitamin K 10 mg
Oral vitamin K 2.5 mg and holding the warfarin
Show the answer and rationale
Answer: C
A. Protamine reverses heparin, not warfarin.
B. FFP is slower, needs large volumes, and is a second choice to PCC.
C.Correct. PCC reverses the INR within minutes, and IV vitamin K sustains the reversal.
D. Oral vitamin K takes many hours and is far too slow for ICH.
For life-threatening warfarin-associated bleeding such as ICH, guidelines recommend 4-factor prothrombin complex concentrate (dosed by INR and weight) for rapid correction plus IV vitamin K (5–10 mg) to sustain it after the PCC wears off. FFP is slower and requires large volumes. A mechanical valve does not prevent reversal for life-threatening bleeding; the timing of restarting anticoagulation is decided jointly by the neurology or neurosurgery and cardiology teams.
A patient with an acute DVT is started on warfarin, and the provider orders enoxaparin to continue for at least 5 days AND until the INR is 2 or higher for 24 hours. The patient asks why both drugs are needed. The nurse’s BEST explanation is that warfarin:
Has no effect on the INR until day 5
Takes 5 days to be absorbed from the gut
Lowers protein C first, briefly raising clotting risk
Works immediately but needs heparin to reach full strength
Show the answer and rationale
Answer: C
A. The INR often rises within 2 to 3 days from factor VII depletion, before the full antithrombotic effect is present, which is exactly why the overlap is needed.
B. Warfarin is absorbed within hours. The delay is in depleting the existing clotting factors, not in absorption.
C.Correct. Early warfarin depletes the natural anticoagulant protein C before the clotting factors fall, so a heparin overlap is needed.
D. Warfarin has a delayed onset, and its full effect takes days.
Warfarin inhibits vitamin K–dependent factors (II, VII, IX, X) and proteins C and S. Protein C and factor VII have short half-lives and fall first, while prothrombin (II) falls last, so full anticoagulation takes about 5 days, and early therapy can be transiently procoagulant (warfarin skin necrosis). A parenteral anticoagulant is overlapped for at least 5 days and until the INR is in range for 24 hours. DOACs have largely replaced this approach for many patients.
Reference range: MedlinePlus Medical Encyclopedia ranges (National Library of Medicine, reviewed 2024–2026); ABIM laboratory reference ranges (January 2026) for hemoglobin, hematocrit and potassium; Merck Manual for ionized calcium; the heparin label for the aPTT target; ASHP/IDSA 2020 vancomycin guideline
For education and exam preparation only. Reference ranges and critical values vary by laboratory. Follow your facility’s policy and the prescriber’s orders.